Skip to main content
. 2016 Jun 28;8(18):770–778. doi: 10.4254/wjh.v8.i18.770

Figure 6.

Figure 6

Forest plot for serious adverse event rate after yttrium-90 radioembolization and transarterial chemoembolization. A non-significant trend in favor of Y90RE was observed (OR = 0.70, 0.38-1.30, P = 0.26), but with a high evidence of heterogeneity (I2 = 52%; P = 0.05). Y90RE: Yttrium-90 radioembolization; TACE: Transarterial chemoembolization; OR: Odds ratio.